Philip Astley-Sparke

2020

In 2020, Philip Astley-Sparke earned a total compensation of $2.2M as Chief Executive Officer at Replimune Group, a 19% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$176,196
Option Awards$1,541,213
Salary$437,754
Total$2,155,164

Astley-Sparke received $1.5M in option awards, accounting for 72% of the total pay in 2020.

Astley-Sparke also received $176.2K in non-equity incentive plan and $437.8K in salary.

Rankings

In 2020, Philip Astley-Sparke's compensation ranked 5,192nd out of 13,090 executives tracked by ExecPay. In other words, Astley-Sparke earned more than 60.3% of executives.

ClassificationRankingPercentile
All
5,192
out of 13,090
60th
Division
Manufacturing
2,133
out of 5,617
62nd
Major group
Chemicals And Allied Products
853
out of 2,248
62nd
Industry group
Drugs
734
out of 1,948
62nd
Industry
Biological Products, Except Diagnostic Substances
176
out of 411
57th
Source: SEC filing on July 29, 2020.

Astley-Sparke's colleagues

We found four more compensation records of executives who worked with Philip Astley-Sparke at Replimune Group in 2020.

2020

Robert Coffin

Replimune Group

President and Chief Research & Development Officer

2020

Jean Franchi

Replimune Group

Chief Financial Officer

2020

Howard Kaufman

Replimune Group

Chief Medical Officer

2020

Pamela Esposito

Replimune Group

Chief Business Officer

News

In-depth

You may also like